Inventor · disambiguated record
Konrad Kauper
Also filed as: KAUPER KONRAD · KAUPER KONRAD A
10 granted patents·7 pending applications·50 citations·filing 2006–2024
88Inventor score
Top patents by PatentIndex Score
17 records- 0192US7820195B2Micronized device for the delivery of biologically active molecules and methods of use thereofNEUROTECH USA INC·Filed 2006·Granted Oct 26, 2010·16 cites·25 claims
- 0289US12485087B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2024·Granted Dec 2, 2025·0 cites·15 claims
- 0388US11207266B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2019·Granted Dec 28, 2021·2 cites·16 claims
- 0488US10456356B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2016·Granted Oct 29, 2019·6 cites·9 claims
- 0587US10195140B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2017·Granted Feb 5, 2019·5 cites·15 claims
- 0686US12357566B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2023·Granted Jul 15, 2025·0 cites·15 claims
- 0781US9265814B2Micronized device for the delivery of biologically active molecules and methods of use thereofKAUPER KONRAD·Filed 2006·Granted Feb 23, 2016·9 cites·4 claims
- 0877US2022071897A1Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2021·Application pending·0 cites
- 0976US9925219B2Encapsulated cell therapy cartridgeNEUROTECH USA INC·Filed 2014·Granted Mar 27, 2018·7 cites·48 claims
- 1076US9149427B2Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofLING VINCENT·Filed 2011·Granted Oct 6, 2015·5 cites·39 claims
- 1156US2024180686A1System, apparatuses, devices, and methods for an analyte diffusive implantable deviceNEUROTECH USA INC·Filed 2020·Application pending·0 cites
- 1256US2024180682A1System, apparatuses, devices, and methods for packaging an analyte diffusive implantable deviceNEUROTECH USA INC·Filed 2020·Application pending·0 cites
- 1346US2010272780A1CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOFLING VINCENT·Filed 2010·Application pending·0 cites
- 1442US10004804B2Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofNEUROTECH USA INC·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
- 1542US2016120695A1Use of pedf in an encapsulated cell-based delivery systemNEUROTECH USA INC·Filed 2015·Application pending·0 cites
- 1642US2015024024A1Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses ThereofTAO WENG·Filed 2010·Application pending·0 cites
- 1742US2011111008A1Use of PEDF in an Encapsulated Cell-Based Delivery SystemTAO WENG·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →